About Ela Bali

Ela Bali is a partner at JSA’s competition law practice, with more than 10 years of experience. She advises clients on merger control, cartels, abuse of dominance, and compliance. She has secured CCI approvals for complex deals, including ChemChina’s USD44 billion acquisition of Syngenta. Ela has been recognised by Chambers and Partners and is ranked in Competition/Antitrust in the Chambers Asia-Pacific Guide 2025 and the Chambers Global Guide 2025.

Contributions to Global Practice Guide

Merger Control Trends and Developments in India

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.